Shorter distances from PD-L1- tumor cells to PD-L1- macrophages during the combination treatment also predicted improved OS (p = 0.018, Figure 7E) and PFS (p = 0.008, Figure 7F). This evidence concerns the gene CD274 and neoplasm.